149 related articles for article (PubMed ID: 8091469)
1. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second- and third-generation anti-HCV assays.
Couroucé AM; Le Marrec N; Girault A; Ducamp S; Simon N
Transfusion; 1994 Sep; 34(9):790-5. PubMed ID: 8091469
[TBL] [Abstract][Full Text] [Related]
2. Early antihepatitis C virus response with second-generation C200/C22 ELISA.
van der Poel CL; Bresters D; Reesink HW; Plaisier AA; Schaasberg W; Leentvaar-Kuypers A; Choo QL; Quan S; Polito A; Houghton M
Vox Sang; 1992; 62(4):208-12. PubMed ID: 1322611
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.
Rossini A; Gazzola GB; Ravaggi A; Agostinelli E; Biasi L; Albertini A; Radaeli E; Cariani E
Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954
[TBL] [Abstract][Full Text] [Related]
4. Immunologic events during the incubation period of hepatitis C virus infection: the role of antibodies to E2 glycoprotein. Multicentre Hemodialysis Cohort Study on Viral Hepatitis.
Psichogiou M; Katsoulidou A; Vaindirli E; Francis B; Lee SR; Hatzakis A
Transfusion; 1997 Aug; 37(8):858-62. PubMed ID: 9280333
[TBL] [Abstract][Full Text] [Related]
5. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction.
Bååth L; Widell A; Nordenfelt E
J Virol Methods; 1992 Dec; 40(3):287-96. PubMed ID: 1282130
[TBL] [Abstract][Full Text] [Related]
6. Significance of highly positive c22-3 "indeterminate" second-generation hepatitis C virus (HCV) recombinant immunoblot assay (RIBA) and resolution by third-generation HCV RIBA.
Pawlotsky JM; Fleury A; Choukroun V; Deforges L; Roudot-Thoraval F; Aumont P; Duval J; Dhumeaux D
J Clin Microbiol; 1994 May; 32(5):1357-9. PubMed ID: 7519631
[TBL] [Abstract][Full Text] [Related]
7. Confirmation of hepatitis C infection: a comparison of five immunoblot assays.
Zaaijer HL; Vrielink H; van Exel-Oehlers PJ; Cuypers HT; Lelie PN
Transfusion; 1994 Jul; 34(7):603-7. PubMed ID: 7519796
[TBL] [Abstract][Full Text] [Related]
8. New-generation RIBA hepatitis C strip immunoblot assays.
Polito AJ; DiNello RK; Quan S; Andrews W; Rose J; Lee F; Nelles M; Lee S
Beitr Infusionsther; 1992; 30():17-33. PubMed ID: 1284698
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors.
Tobler LH; Busch MP; Wilber J; Dinello R; Quan S; Polito A; Kochesky R; Bahl C; Nelles M; Lee SR
Transfusion; 1994 Feb; 34(2):130-4. PubMed ID: 8310482
[TBL] [Abstract][Full Text] [Related]
10. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.
François M; Dubois F; Brand D; Bacq Y; Guerois C; Mouchet C; Tichet J; Goudeau A; Barin F
J Clin Microbiol; 1993 May; 31(5):1189-93. PubMed ID: 7684749
[TBL] [Abstract][Full Text] [Related]
12. Third-generation hepatitis C virus tests in asymptomatic anti-HCV-positive blood donors.
Craxì A; Valenza M; Fabiano C; Magrin S; Fiorentino G; Diquattro O; Pagliaro L
J Hepatol; 1994 Nov; 21(5):730-4. PubMed ID: 7890886
[TBL] [Abstract][Full Text] [Related]
13. Predictive markers for hepatitis C antibody ELISA specificity in Australian blood donors.
Hyland CA; Kearns S; Young IF; Battistutta D; Morgan CL
Transfus Med; 1992 Sep; 2(3):207-13. PubMed ID: 1285010
[TBL] [Abstract][Full Text] [Related]
14. Serodiagnosis of chronic hepatitis C in Japan by second-generation recombinant immunoblot assay.
Yuki N; Hayashi N; Hagiwara H; Takehara T; Oshita M; Kasahara A; Fusamoto H; Kamada T
J Hepatol; 1993 Feb; 17(2):170-4. PubMed ID: 8383157
[TBL] [Abstract][Full Text] [Related]
15. Increased detection of antibody to hepatitis C virus in renal transplant patients by third-generation assays.
Soffredini R; Rumi M; Lampertico P; Aroldi A; Tarantino A; Ponticelli C; Colombo M
Am J Kidney Dis; 1996 Sep; 28(3):437-40. PubMed ID: 8804244
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of third-generation screening and confirmatory assays for HCV antibodies.
Uyttendaele S; Claeys H; Mertens W; Verhaert H; Vermylen C
Vox Sang; 1994; 66(2):122-9. PubMed ID: 7514324
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus among blood donors: follow-up study.
Alonso C; Pedroso ML; de Sanjosé S; Montcharmont P; Chèvre JM; Boucaud MJ; Lambert V; Cortey ML; Trépo C
Transfusion; 1994 Jun; 34(6):527-30. PubMed ID: 8023395
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors.
Salmerón FJ; Palacios A; Pérez-Ruiz M; Torres C; Oyonarte S; Fernández-Montoya A; Ruiz-Extremera A
Dig Dis Sci; 1996 Oct; 41(10):1933-8. PubMed ID: 8888703
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of first- and second-generation RIBA kits for detection of antibody to hepatitis C virus.
Chaudhary RK; MacLean C
J Clin Microbiol; 1991 Oct; 29(10):2329-30. PubMed ID: 1719025
[TBL] [Abstract][Full Text] [Related]
20. Recombinant immunoblot assay reaction patterns and hepatitis C virus RNA in blood donors and non-A, non-B hepatitis patients.
Bresters D; Zaaijer HL; Cuypers HT; Reesink HW; Winkel IN; van Exel-Oehlers PJ; van Drimmelen AA; Jansen PL; van der Poel CL; Lelie PN
Transfusion; 1993 Aug; 33(8):634-8. PubMed ID: 7688158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
